Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Shimada

Showing results (151-160 of 295) with videos related to

Pageof 30
Sort By:
International Journal of Clinical Oncology|January 22, 2018
A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinomaShuji Hiramoto, Ken Kato, Hirokazu Shoji, et al.
Cancer Science|May 28, 2014
Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resectionHirokazu Shoji, Yasuhide Yamada, Hirokazu Taniguchi, et al.
Japanese Journal of Clinical Oncology|June 19, 2009
Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancerNatsuko Tsuda Okita, Yasuhide Yamada, Daisuke Takahari, et al.
Journal of Cancer Research and Clinical Oncology|February 12, 2009
Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experienceKenji Hashimoto, Hiroshi Mayahara, Atsuo Takashima, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2015
S-1 and irinotecan with or without bevacizumab versus 5-fluorouracil and leucovorin plus oxaliplatin with or without bevacizumab in metastatic colorectal cancer: a pooled analysis of four phase II studiesSatoru Iwasa, Kengo Nagashima, Tatsuro Yamaguchi, et al.
Cancer Research|November 18, 2008
Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecanTakako Eguchi Nakajima, Kazuyoshi Yanagihara, Misato Takigahira, et al.
Investigational New Drugs|July 6, 2011
Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancerKen Kato, Keisho Chin, Takaki Yoshikawa, et al.
Japanese Journal of Clinical Oncology|July 10, 2019
Efficacy and safety of pemetrexed plus cisplatin as first-line chemotherapy in advanced malignant peritoneal mesotheliomaYusuke Nagata, Ryoichi Sawada, Atsuo Takashima, et al.
Japanese Journal of Clinical Oncology|September 8, 2010
A multicenter phase-II study of 5-FU, leucovorin and oxaliplatin (FOLFOX6) in patients with pretreated metastatic colorectal cancerKen Kato, Yoshitaka Inaba, Yasushi Tsuji, et al.
The Journal of Clinical Investigation|September 17, 2004
A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiationKenji Sugimoto, Mutsuhiro Ohata, Jun Miyoshi, et al.
Pageof 30

Showing results (151-160 of 295) with videos related to

Sort By:
Pageof 30
International Journal of Clinical Oncology|January 22, 2018
A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinomaShuji Hiramoto, Ken Kato, Hirokazu Shoji, et al.
Cancer Science|May 28, 2014
Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resectionHirokazu Shoji, Yasuhide Yamada, Hirokazu Taniguchi, et al.
Japanese Journal of Clinical Oncology|June 19, 2009
Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancerNatsuko Tsuda Okita, Yasuhide Yamada, Daisuke Takahari, et al.
Journal of Cancer Research and Clinical Oncology|February 12, 2009
Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experienceKenji Hashimoto, Hiroshi Mayahara, Atsuo Takashima, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2015
S-1 and irinotecan with or without bevacizumab versus 5-fluorouracil and leucovorin plus oxaliplatin with or without bevacizumab in metastatic colorectal cancer: a pooled analysis of four phase II studiesSatoru Iwasa, Kengo Nagashima, Tatsuro Yamaguchi, et al.
Cancer Research|November 18, 2008
Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecanTakako Eguchi Nakajima, Kazuyoshi Yanagihara, Misato Takigahira, et al.
Investigational New Drugs|July 6, 2011
Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancerKen Kato, Keisho Chin, Takaki Yoshikawa, et al.
Japanese Journal of Clinical Oncology|July 10, 2019
Efficacy and safety of pemetrexed plus cisplatin as first-line chemotherapy in advanced malignant peritoneal mesotheliomaYusuke Nagata, Ryoichi Sawada, Atsuo Takashima, et al.
Japanese Journal of Clinical Oncology|September 8, 2010
A multicenter phase-II study of 5-FU, leucovorin and oxaliplatin (FOLFOX6) in patients with pretreated metastatic colorectal cancerKen Kato, Yoshitaka Inaba, Yasushi Tsuji, et al.
The Journal of Clinical Investigation|September 17, 2004
A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiationKenji Sugimoto, Mutsuhiro Ohata, Jun Miyoshi, et al.
Pageof 30